350 related articles for article (PubMed ID: 21736932)
1. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
2. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569
[TBL] [Abstract][Full Text] [Related]
3. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):627-34. PubMed ID: 21855303
[TBL] [Abstract][Full Text] [Related]
4. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
Kuo YC; Lee CL
Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
[TBL] [Abstract][Full Text] [Related]
5. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
Kuo YC; Wang CC
Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
[TBL] [Abstract][Full Text] [Related]
6. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
[TBL] [Abstract][Full Text] [Related]
8. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Lin PI; Wang CC
Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
[TBL] [Abstract][Full Text] [Related]
9. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
Kuo YC; Ko HF
Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
[TBL] [Abstract][Full Text] [Related]
10. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Kuo YC; Kuo CY
Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
[TBL] [Abstract][Full Text] [Related]
11. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
12. Preparation of size tunable amphiphilic poly(amino acid) nanoparticles.
Kim H; Akagi T; Akashi M
Macromol Biosci; 2009 Sep; 9(9):842-8. PubMed ID: 19422015
[TBL] [Abstract][Full Text] [Related]
13. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells.
Kuo YC; Chen HH
J Drug Target; 2010 Jul; 18(6):447-56. PubMed ID: 20528098
[TBL] [Abstract][Full Text] [Related]
14. Polyampholyte nanoparticles prepared by self-complexation of cationized poly(γ-glutamic acid) for protein carriers.
Shen H; Akagi T; Akashi M
Macromol Biosci; 2012 Aug; 12(8):1100-5. PubMed ID: 22730314
[TBL] [Abstract][Full Text] [Related]
15. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700
[TBL] [Abstract][Full Text] [Related]
16. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
[TBL] [Abstract][Full Text] [Related]
17. Preparation of pixantrone/poly(γ-glutamic acid) nanoparticles through complex self-assembly for oral chemotherapy.
Meng L; Ji B; Huang W; Wang D; Tong G; Su Y; Zhu X; Yan D
Macromol Biosci; 2012 Nov; 12(11):1524-33. PubMed ID: 23008063
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
